Has the use of RELPAX® been associated with rebound headache?
Overuse of all triptans has been reported primarily in patients with chronic daily headache.1
The diagnostic criteria for triptan-overuse headache according to the International Headache Society (IHS), which can accessed at www.ihs-headache.org are as follows:
- Headache present on ≥15 days/month, which developed or markedly worsened during medication overuse and which resolves or reverts to its previous pattern within 2 months after discontinuation of overused medication.2
- Triptan intake (any formulation) on ≥10 days/month on a regular basis for > 3 months.2
- Relpax®(eletriptan hydrobromide) Product Information
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33(9) 629–808. www.ihs-headache.org/ichd-guidelines.
Tips and Tricks
Contact Pfizer Medical Information
Monday to Friday 9am – 5pm EST